April 16-18, 2024
Javits Center, NYC


Pharmaceutical Technology and BioPharm International – Editor's Series

July 28, 2020, 11:00 AM EDT | 8:00 AM PDT | 4:00 PM BST | 5:00 PM CEST

Editors’ Series: Overcoming Commercialization Challenges for Cell Therapies and Gene Therapies


Alan Moore
Chief Strategy Officer
The Discovery Labs

Christopher Murphy
Vice President and General Manager, Viral Vector Services
Thermo Fisher Scientific, Pharma Services Group

Thomas VanCott, PhD
Global Head of Product Development, Cell & Gene Therapy
Catalent Cell & Gene Therapy


Rita Peters
Editorial Director
BioPharm International and Pharmaceutical Technology

Feliza Mirasol
Science Editor
BioPharm International and Pharmaceutical Technology

July 29, 2020, 11:00 AM EDT | 8:00 AM PDT | 4:00 PM BST | 5:00 PM CEST

Editors’ Series: Cell and Gene Therapies: Laying the Foundation for a New Supply Chain


Alberto Santagostino
Senior Vice President and Head of Cell and Gene Therapies
Lonza Pharma and Biotech

Amy DuRoss
Co-Founder and CEO

Mark Sawicki
Chief Commercial Officer


Agnes Shanley
Senior Editor
BioPharm International and Pharmaceutical Technology

May 26

Strategies for Designing Adaptable, Resilient Bio/Pharma Facilities


Jason S. Collins
AIA, Director, Process Architecture

Curt Firestine
Mechanical Engineer


Rita Peters
Editorial Director
Pharmaceutical Technology

Jennifer Markarian
Manufacturing Editor
Pharmaceutical Technology

April 28

Ensuring the Continuous Supply of Quality Drug Products During Uncertain Times

Mary Blenn, Vice-President, Global Supply Chain, Cytiva
Lisia Marina Scholz Dias, Lead Application Engineer, Applied Materials
Steve Goldman, Head of Steve Goldman Associates, A Risk Management and Business Continuity Consultancy
David Light, CEO of Valisure
Ron Najafi, CEO of Emery Pharma
Susan Schniepp, A Distinguished Fellow for Regulatory Compliance Associates
Angelo Stracquatanio, CEO,
Japp Venema, CSO, USP



Exploring Enhanced Selectivity of Innovative Ion Exchange Resin in ADC Polishing

Efficient manufacturing of biopharmaceutical drugs such as ADCs is challenging with respect to low costs & high drug efficiency. Application of a recently developed IEX resin for downstream purification of ADCs enabled an efficient DAR species separation.

Romas Skudas - Lab Head – Process Solutions Chromatography R&D, MilliporeSigma
Annika Holzgreve - Applications Engineer Process Solutions Chromatography R&D, MilliporeSigma


Re-imagining Vaccine Manufacturing to address Global Health Challenges

Developing vaccines and manufacturing large doses in an emergency is often constrained by existing platforms and facility set ups. Vaccine manufacturing need to evolve to tackle future global health challenges.

Anissa Boumlic-Courtade, Ph.D., Head of Global Vaccine & Plasma Segments – MilliporeSigma


Data Driven Strategies and Considerations for Scalable Purification of Plasmid DNA for Use in Vaccine Manufacturing

Plasmid DNA presents unique manufacturing challenges. This webinar presents significant process understanding and scalable solutions for pDNA Purification from harvest to bulk filtration.  

Youness Cherradi, Senior Process Development Scientist, MilliporeSigma


Unlocking the Potential of mRNA Vaccines and Therapeutics

This webinar will focus on the potential of mRNA therapies and on the manufacturing process associated challenges and solutions.

Manuel Brantner, MSc, Associate Director Vaccines & Plasma Segment, MilliporeSigma
Nargisse El-Hajjami, PhD, Associate Director for Cell and Gene Therapy, MilliporeSigma


June 8

Better Sensor Technologies for Modern Greenhouses

Controlled Environment Agriculture is one of the fastest growing segments in food markets around the world. As the demand for locally grown and organic products continues to rise, the demand is being met by today’s modern greenhouses, vertical, and container farms. Advancements in technology and techniques available today allow growers to produce more, with greater consistency, while using less energy and resources.

You’ll come away understanding:

  • How modern humidity, temperature and CO2 sensors can help you more effectively balance resource use and crop growth
  • Why you should focus on these measurements - including why they’re considered “safe”
  • How these parameters are measured accurately and why they’re so important
  • The technology behind the measurements
  • How to select instruments that meet your needs and focus on support, maintenance, stability and sustainability

This webinar is 45 minutes long and includes a Q&A session.

Speakers, moderators, etc.:

Justin Walsh is a Business Development Engineer at Vaisala. He has been working with electro-chemical and industrial measurement technologies for over 16 years, ensuring product quality, measurement accuracy and environmental safety. His experience includes application support with Thermo, environmental consulting, emergency planning and response with the US EPA, and a degree in Environmental Engineering from the University of Miami.